The intricate relationship between metabolic disorders & obesity plays a pivotal role in diabetes pathogenesis. Excess adiposity, particularly visceral fat accumulation, promotes insulin resistance and chronic inflammation, increasing the likelihood of type 2 diabetes. Dysregulated lipid metabolism and hormonal imbalances further exacerbate metabolic dysfunction, contributing to conditions such as metabolic syndrome and non-alcoholic fatty liver disease. Emerging research highlights the role of gut microbiota and genetic predisposition in metabolic health. Novel therapeutic strategies, including GLP-1 receptor agonists, bariatric surgery, and personalized nutrition plans, are proving effective in managing obesity-driven metabolic disorders. A multidisciplinary approach integrating pharmacotherapy, lifestyle interventions, and early screening is essential for preventing disease progression.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti